Image: Wikimedia Commons
Moscow/Sputnik: US pharmaceutical company Pfizer announced in a press release on Tuesday it was launching a pilot program that aims to inform the delivery and distribution of its coronavirus vaccine in the US states of Rhode Island, Texas, New Mexico and Tennessee.
"To build on our coordination with the relevant U.S. agencies, Pfizer launched this pilot program to help better support the states’ planning, deployment, and administration of the COVID-19 vaccine candidate. Learnings from this program will be adapted for usage across other states to help them create effective immunization programs for this vaccine," the company said in a press release.
According to Pfizer, the four US states were selected due to their differences in overall size, diversity of populations, and immunization infrastructure, as well as the need to reach populations both in rural and urban areas.
In a disclaimer of future preferential benefits for these four states, the company has stressed that they "will not receive vaccine doses earlier than other states by virtue of this pilot, nor will they receive any differential consideration."
Pfizer developed the vaccine in collaboration with German biotechnology company BioNTech. As the unregistered vaccine is underway with phase 3 clinical trials, the creators have declared above 90-percent efficiency.
- End leprosy discrimination laws ‘without delay’, UN rights expert urges
- Merck and Ridgeback says Molnupiravir medicine demonstrates activity against Omicron variant
- NeoCoV virus: Wuhan scientists warn of new coronavirus strain with higher infection rate, fatality
- WHO: New guidance on treating complications due to unsafe abortion
- Bangladesh registers 15,527 new coronavirus cases in past 24 hours